Skip to content
OpenCapital
Get started

Select Medical Holdings SEM Debt Instrument, Unamortized Discount (Premium), Net

Debt Instrument, Unamortized Discount (Premium), Net at other companies

Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
——

Other financials

Income statement

See full
Revenue$1.4B+5.0%
Gross profit$175.5M-2.8%
Operating income$98.4M-12.7%
Net income$44.0M-22.4%
EPS (diluted)$0.35-20.5%

Balance sheet

See full
Cash & equivalents$25.7M-51.7%
Total debt$3.0B+7.5%
Total equity$1.8B+2.1%
Total assets$6.0B+6.1%

Cash flow

See full
Operating cash flow$37.9M+1,195%
CapEx$58.9M+12.5%
Free cash flow-$21.0M+62.3%

Valuation

See full
Market cap$2.05B-6.2%

Profitability

See full
Gross margin11.3%-0.5pp
Operating margin5.8%+0.8pp
Net margin2.4%-0.9pp
FCF margin2.8%-4.1pp

Returns & leverage

See full
Return on equity7.7%-3.6pp
Debt / equity1.7×+0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Select Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet.

The official record: Select Medical Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Select Medical Holdings's debt instrument, unamortized discount (premium), net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Select Medical Holdings's debt instrument, unamortized discount (premium), net?
Select Medical Holdings (SEM) reported debt instrument, unamortized discount (premium), net of $2.19M in Q1 2026.
How has Select Medical Holdings's debt instrument, unamortized discount (premium), net changed year-over-year?
Select Medical Holdings's debt instrument, unamortized discount (premium), net decreased by 15.4% year-over-year, from $2.59M to $2.19M.
What is the long-term trend for Select Medical Holdings's debt instrument, unamortized discount (premium), net?
Over 5 years (2020 to 2025), Select Medical Holdings's debt instrument, unamortized discount (premium), net has grown at a -38.2% compound annual growth rate (CAGR), from -$25.38M to $2.29M.